Literature DB >> 30575894

LncRNA HOXD-AS1 promotes preeclampsia progression via MAPK pathway.

J Jiang1, Z-M Zhao.   

Abstract

OBJECTIVE: To investigate the role of HOXD-AS1 in preeclampsia and its underlying mechanism. PATIENTS AND METHODS: A total of 50 preeclampsia primiparas and 34 normal pregnancies admitted in our hospital from July 2015 to July 2017 were selected as the study group and control group, respectively. Age, body weight, blood pressure, 24-h urinary protein and neonatal weight were compared between the two groups. HOXD-AS1 expression in the placenta tissues was detected by quantitative Real-time PCR (qRT-PCR). Preeclampsia patients were further assigned into high and low expression group according to their HOXD-AS1 expressions. The relationship between HOXD-AS1 expression and blood pressure, 24-h urinary protein and neonatal weight in preeclampsia patients were analyzed. For in vitro experiments, transfection efficacy of pcDNA-HOXD-AS1 and si-HOXD-AS1 were detected by qRT-PCR. Proliferative and colony formation abilities in BeWo and Wish cells were detected by CCK-8 and colony formation assay, respectively. Moreover, protein expressions of p-p38, p-JNK, and p-ERK were detected by Western blot.
RESULTS: The systolic blood pressure, diastolic blood pressure and urinary protein in preeclampsia patients were higher than those of normal pregnancies. However, neonatal weight in preeclampsia patients was lower than that of normal pregnancies. HOXD-AS1 expressions were gradually increased in normal pregnancies, patients with late onset preeclampsia and patients with early onset preeclampsia sequentially. Additionally, higher levels of systolic pressure, diastolic pressure and 24-h urinary protein, as well as lower neonatal weight, were observed in preeclampsia patients with high expression of HOXD-AS1 than those with low expression. In vitro results demonstrated that proliferative and colony formation abilities in trophoblasts were elevated after HOXD-AS1 knockdown. Western blot data illustrated that protein expressions of p-p38 and p-JNK were decreased, while p-ERK expression was increased after overexpression of HOXD-AS1 in trophoblasts.
CONCLUSIONS: HOXD-AS1 participates in the development and progression of preeclampsia by regulating trophoblast proliferation via the MAPK pathway.

Entities:  

Year:  2018        PMID: 30575894     DOI: 10.26355/eurrev_201812_16618

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  miR-335 targets CRIM1 to promote the proliferation and inhibit the apoptosis of placental trophoblast cells in preeclamptic rats.

Authors:  Liuyan Jiang; Meiyan Li; Haisi Gan; Li Yang; Fengjuan Lin; Min Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  EZH2 enhances proliferation and migration of trophoblast cell lines by blocking GADD45A-mediated p38/MAPK signaling pathway.

Authors:  Xuefang Qian; Yuying Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Identifying key genes and drug screening for preeclampsia based on gene expression profiles.

Authors:  Zhengfang Xu; Chengjiang Wu; Yanqiu Liu; Nian Wang; Shujun Gao; Shali Qiu; Zhutao Wang; Jing Ding; Lubin Zhang; Hui Wang; Weijiang Wu; Bing Wan; Jun Yu; Jie Fang; Peifang Yang; Qixiang Shao
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 4.  Role of Circular RNAs in Preeclampsia.

Authors:  Ningyi Jia; Jian Li
Journal:  Dis Markers       Date:  2019-05-02       Impact factor: 3.434

5.  Serum lncRNAs in early pregnancy as potential biomarkers for the prediction of pregnancy-induced hypertension, including preeclampsia.

Authors:  Chenguang Dai; Chenyang Zhao; Minglu Xu; Xinshuang Sui; Li Sun; Yang Liu; Mengqi Su; Hongling Wang; Yue Yuan; Song Zhang; Jing Shi; Jingxia Sun; Yue Li
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-17       Impact factor: 8.886

6.  lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis.

Authors:  Dan Tang; Li Geng; Jing Ma
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.